title: Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth.
abstract: Oxysterols are oxidized derivatives of cholesterol that are generated enzymatically or through autoxidation. Initially identified as important lipid signaling molecules in the context of atherosclerosis and inflammation, accumulated evidence indicates that these lipid-signaling molecules can have pleiotropic effects on the fate and function of the immune system. These effects range from the regulation of immune cell survival and proliferation to chemotaxis and antiviral immunity. New studies now indicate that tumor-derived oxysterols can serve to subvert the immune system by recruiting protumorigenic neutrophils into the tumor microenvironment. The consequence of this recruitment is the generation of proangiogenic factors and matrix metalloproteinase proteins that provide a tumor a significant growth and survival advantage. In combination with other recent studies, these data highlight the ongoing cross talk between sterol metabolism and the immune system, and they raise the intriguing possibility that targeting oxysterol pathways could serve as a novel therapeutic approach in the war on cancer.
authors: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, CA 90095, USA.
authors: Autumn G
authors: AG
authors: York
authors: Steven J
authors: SJ
authors: Bensinger
mesh_terms: D000818:Animals; D006706:Homeostasis / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D008954:Models, Biological; D009369:Neoplasms / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D015398:Signal Transduction / Q000276:immunology; D013261:Sterols / Q000378:metabolism*
chemical_list: D013261:Sterols
references: J Clin Invest. 2012 Jan;122(1):337-47
references: 22156197
references: Cell. 2008 Jul 11;134(1):97-111
references: 18614014
references: Cell. 2013 May 23;153(5):1025-35
references: 23706740
references: Immunity. 2013 Jan 24;38(1):106-18
references: 23273843
references: Nat Immunol. 2013 Aug;14(8):831-9
references: 23770640
references: Nat Rev Immunol. 2011 Sep 23;11(10):702-11
references: 21941296
references: Cell. 2011 Apr 29;145(3):341-55
references: 21529710
references: Nature. 2008 Jul 24;454(7203):470-7
references: 18650918
references: Biochim Biophys Acta. 2000 Dec 15;1529(1-3):126-35
references: 11111082
references: Immunity. 2009 Aug 21;31(2):245-58
references: 19646905
references: Cell. 2011 Mar 4;144(5):646-74
references: 21376230
references: Cancer Res. 2013 Jan 15;73(2):571-82
references: 23204236
references: Clin Cancer Res. 2013 Feb 1;19(3):643-56
references: 23149820
references: J Clin Oncol. 2009 Oct 1;27(28):4709-17
references: 19720929
references: J Clin Invest. 2002 May;109(9):1125-31
references: 11994399
references: Nat Med. 2010 Jan;16(1):98-105
references: 20037595
references: Circ Res. 2013 May 24;112(11):1456-65
references: 23572498
references: Immunity. 2013 Jan 24;38(1):92-105
references: 23273844
references: Nature. 2011 Jul 27;475(7357):519-23
references: 21796211
references: Nature. 2011 Jul 27;475(7357):524-7
references: 21796212
references: Nat Rev Mol Cell Biol. 2012 Mar 14;13(4):213-24
references: 22414897